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1,2-Diarachidonoyl-sn-glycero-3-phosphoethanolamine (DAPE) induces both necrosis/necroptosis and
apoptosis of NCI-H28 malignant pleural mesothelioma (MPM) cells. The present study was conducted to
understand the mechanism for DAPE-induced apoptosis of NCI-H28 cells. DAPE induced caspase-
independent apoptosis of NCI-H28 malignant pleural mesothelioma (MPM) cells, and the effect of
DAPE was prevented by antioxidants or an inhibitor of NADPH oxidase (NOX). DAPE generated reactive
oxygen species (ROS) and inhibited activity of thioredoxin (Trx) reductase (TrxR). DAPE decreased an
association of apoptosis signal-regulating kinase 1 (ASK1) with thioredoxin (Trx), thereby releasing ASK1.
DAPE activated p38 mitogen-activated protein kinase (MAPK), which was inhibited by an antioxidant or
knocking-down ASK1. In addition, DAPE-induced NCI-H28 cell death was also prevented by knocking-
down ASK1. Taken together, the results of the present study indicate that DAPE stimulates NOX-
mediated ROS production and suppresses TrxR activity, resulting in the decrease of reduced Trx and
the dissociation of ASK1 from a complex with Trx, allowing sequential activation of ASK1 and p38 MAPK,
to induce apoptosis of NCI-H28 MPM cells.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
MPM is an aggressive malignant tumor with very poor prog-
nosis, and exposure to asbestos ﬁbers is themajor pathogenic factor
for MPM as well as ﬁbrotic lung disease and lung cancer (1).
Asbestos causes DNA double strand breaks, chromosomal aberra-
tions, and abnormal chromosome segregation (2,3). Asbestos in-
duces genotoxicities directly or indirectly by producing ROS (4).
Asbestos affects expression of genes involved in integrin-mediated
signaling pathways, MAPK pathways, and IkB/NFkB pathways (5).
Asbestos stimulates secretion of tumor necrosis factor a (TNFa) and
activates NFkB cascades, to prevent MPM cells from apoptosis, i.e.,
to promote proliferation/differentiation of MPM cells (6).
MPM cells are resistant to ROS-induced oxidative stress or ra-
diation. This may be due to the potential antioxidant mechanisms
in MPM cells. Expression of mitochondrial manganese superoxideizaki).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).dismutase and enzymes associated with glutathione metabolism
such as glutathione-S-transferase and g-glutamylcysteinyl syn-
thetase is upregulated in MPM cells (7e11). In addition, Trx may be
implicated in the resistance to oxidants and cytotoxic drugs. In
response to a variety of factors such as oxidative stress, tumor-
promoting agents, and cytotoxic drugs expression of Trx is
induced (12e14). Expression of Trx and TrxR is upregulated inMPM
cells (15), and higher concentrations of serum Trx are found in
MPM patients (16).
The Trx system, which is composed of NADPH, cytosolic and
mitochondrial Trx, and TrxR, plays a crucial role in the regulation of
cancer cell proliferation and invasion (17e20). TrxR reduces and
activates Trx, and thioredoxin-interacting protein (TXNIP) nega-
tively regulates Trx. Trx is a 12 kD multifunctional protein and has
an active site with two redox-active cysteine residues (-Trp-Cys-
Gly-Pro-Cys-) catalyzing protein disulﬁde reductions. Trx keeps the
cellular redox state and regulates cell proliferation by acting as an
electron donor of ribonucleotide reductase, essential for DNA syn-
thesis (21,22). Trx, alternatively, regulates p53-mediated p21 ac-
tivity and modulates gene expression through thiol redox control
over transcription factors such as NFkB and AP-1 (23e26).nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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dipalmitoleoyl-sn-glycero-3-phosphoethanolamine (DPPE) induced
apoptosis of NCI-H28 MPM cells by enhancing activities of protein
phosphatase 2A (PP2A) and protein tyrosine phosphatase 1B (PTP1B)
(27). We have lately found that another phosphatidylethanolamine
DAPE induced both necrosis/necroptosis and apoptosis of NCI-H28
MPM cells (28). DAPE-induced necrosis/necroptosis was mediated
by RIP1 kinase and caused by cyclophilin D-dependent mitochon-
drial damage in association with ROS generation, to reduce intra-
cellular ATP levels (28). The mechanism underlying DAPE-induced
apoptosis of NCI-H28 cells, however, remains to be elucidated as yet.
The present study was designed to answer this issue. We show here
that DAPE induces apoptosis of NCI-H28 cells through a pathway
along anASK1/MKK(3/6)/p38MAPK axis under the regulation of Trx.
2. Materials and methods
2.1. Cell culture
NCI-H28 cell line was purchased from American Type Culture
Collection (Manassas, VA, USA). Cells were grown in RPMI-1640
medium supplemented with 10% (v/v) heat-inactivated FBS,
0.003% (w/v) L-glutamine, penicillin (ﬁnal concentration,100 U/ml),
and streptomycin (ﬁnal concentration, 0.1 mg/ml), in a humidiﬁed
atmosphere of 5% CO2 and 95% air at 37 C.
2.2. Assay of cell viability
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) assay was performed by the method as previously
described (27).
2.3. Terminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL) staining
TUNEL staining was performed by the method as previously
described (27).
2.4. Enzymatic assay of caspase activity
Caspase activity was measured by the method as previously
described (29). The substrate peptides used were as follows: Ac-
Asp-Glu-Val-Asp-MCA for a caspase-3 substrate peptide, Ac-Leu-
Glu-Val-Asp-AFC for a caspase-4 substrate peptide, Ac-Ile-Glu-
Thr-Asp-MCA for a caspase-8 substrate peptide, and Ac-Leu-Glu-
His-Asp-MCA for a caspase-9 substrate peptide.
2.5. Monitoring of ROS
Cells were incubated in the culture medium containing 10 mM6-
carboxy-20,70-dichlorodihydroﬂuorescein diacetate (carboxy-
H2DCFDA) (Life Technologies, Tokyo, Japan) for 30min at 37 C. ROS
generation in living cells was monitored at 488-nm argon laser
with a confocal scanning laser microscope (LSM 510, Carl Zeiss Co.,
Ltd.) before and after bath-application with DAPE and/or GSH or
VAS. The ﬂuorescent signal intensity in each cell was measured and
summated as an index of ROS production.
2.6. Assay of TrxR activity
TrxR activity was monitored using a TrxR activity colorimetric
assay kit (Biovision, Milpitas, CA, USA). In this assay, TrxR catalyzes
reduction of 5,50-dithiobis (2-nitrobenzoic) acid (DTNB) with
NADPH to 5-thio-2-nitrobenzoic acid (TNB2), and in this reaction
process TNB2 generates a strong yellow color. Cells were harvestedbefore and after treatment with DAPE for periods of time, and then
centrifuged at 800 g for 5 min at 4 C. The pellet was homogenized
on ice in an assay buffer, and then centrifuged at 10,000 g for 15min
at 4 C. The supernatant was reacted with DTNB and NADPH at
25 C for 20 min, and the reaction intensity as a TrxR activity was
measured at an absorbance of 412 nm.
2.7. Immunoprecipitation
Cells were lysed in a lysis buffer [150 mM NaCl, 1 mM EDTA,
1mMEGTA,1mM sodium orthovanadate,1% (v/v) Triton X-100 and
20 mM Tris, pH 7.5] containing 1% (v/v) protease inhibitor cocktail
and 1% (v/v) phosphatase inhibitor cocktail (Nacalai Tesque, Kyoto,
Japan), and then centrifuged at 10,000 g for 15 min at 4 C. Su-
pernatants were incubated with an anti-ASK1 antibody (Cell
Signaling Technology, Inc., Danvers, MA, USA) overnight at 4 C.
Then, protein G sepharose 4 beads (GE Healthcare, Piscataway, NJ,
USA) was added to the extracts and incubated for 2 h at 4 C. Pellets
were washed 5 times with the lysis buffer and dissolved in an SDS
sample buffer for Western blotting.
2.8. Western blotting
Western blotting was performed by the method as previously
described (29) using antibodies against p38, ERK, and phospho-ERK
(p-ERK) (Santa Cruz Biotechnology, Inc., Dallas, Texas, USA); Trx1
(GeneTex, Inc., Irvine, CA, USA); ASK1, phospho-ASK1(p-ASK1),
MKK3, phospho-MKK3 (p-MKK3), MKK4, phospho-MKK4 (p-
MKK4), phospho-p38 (p-p38), JNK, and phospho-JNK (p-JNK) (Cell
Signaling Technology); and b-actin (SIGMA, Missouri, SL, USA).
2.9. Construction and transfection of siRNA
The siRNA silencing the ASK1-targeted gene (ASK1 siRNA) and
the negative control siRNA (NC siRNA) were obtained from Invi-
trogen (Carlsbad, CA, USA). The sequences of ASK1 siRNA used here
were 50-UUAAUAGCAAUUCUGACUUGGUUGC-30, and 50-GCAAC-
CAAGUCAGAAUUGCUAUUAA-30. The NC siRNA contained the
scrambled sequence with the same GC content and nucleic acid
composition. ASK1 siRNA and NC siRNA were reverse-transfected
into cells using a Lipofectamine reagent (Invitrogen). Cells were
used for experiments 48 h after transfection.
2.10. Statistical analysis
The data presented were mean ± standard error of the mean
(SEM). Statistical differences were analyzed by unpaired t-test and
analysis of variance (ANOVA) followed by a Bonferroni correction.
Values of p < 0.05 were considered statistically signiﬁcant.
3. Results
In the MTT assay, DAPE reduced NCI-H28 cell viability in a
treatment time (24e48 h)- and concentration (1e100 mM)-
dependent manner (Fig. 1A). In the TUNEL staining, DAPE obviously
increased the number of TUNEL-positive NCI-H28 cells as
compared with control (Fig. 1B). In the caspase assay, no signiﬁcant
activation of caspase-3, -4, -8, and -9 was obtained with DAPE
(Fig. 1C). Taken together, these results indicate that DAPE induces
caspase-independent apoptosis of NCI-H28 cells.
In the real-time reverse transcription-polymerase chain reac-
tion (RT-PCR) analysis, DAPE had no signiﬁcant effect on expression
of mRNAs for FasL, Fas, Fas-associated death domain protein
(FADD), TNFa, TNFa receptor 1 (TNFR1), TNFR2, TNFR1-associated
death domain protein (TRADD), TNF-related apoptosis-inducing
Fig. 1. DAPE induces caspase-independent apoptosis of NCI-H28 cells. (A) Cells were treated with DAPE at concentrations as indicated for 24 or 48 h, followed by MTT assay. In the
graph, each point represents the mean (±SEM) percentage of basal levels (MTT intensities for untreated cells) (n ¼ 4 independent experiments). (B) TUNEL staining was carried out
in cells before and after treatment with DAPE (100 mM) for 6 h. DIC, differential interference contrast. Bars, 100 mm. (C) Activities of caspase-3, -4, -8, and -9 were assayed in cells
before and after treatment with DAPE (100 mM) for periods of time as indicated. In the graph, each point represents the mean (±SEM) ratio against basal caspase activities (before
treatment with DAPE) (n ¼ 4 independent experiments).
Fig. 2. ROS is implicated in DAPE-induced apoptosis of NCI-H28 cells. MTT assay was
carried out in cells treated with DAPE (100 mM) for 24 h in the presence and absence of
GSH (1 mM) (A), NAC (1 mM) (B), VAS (1 mM) (C), or NSC (10 mM) (D), which was
applied 1 h prior to DAPE treatment. In the graphs, each point represents the mean
(±SEM) percentage of basal levels (MTT intensities for cells untreated with DAPE in the
absence of each inhibitor) (n ¼ 4 independent experiments). P values, unpaired t-test.
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death receptor 3 (DR3), DR4, DR5, and DR6 in NCI-H28 cells
(Fig. S1). This suggests that DAPE-induced apoptosis of NCI-H28
cells is not mediated through death receptors bearing activation
of caspase-8 followed by the effect caspase-3.
Apoptosis-inducing factor (AIF) and AIF-homologous mito-
chondrion-associated inducer of death (AMID) induce caspase-
independent apoptosis by accumulating in the nucleus. Endonu-
clease G (EndoG), alternatively, induces caspase-independent
apoptosis by cleaving DNA. DAPE had no effect on total expres-
sion of AIF, AMID, and EndoG (Fig. S2AeC) or nuclear localization of
AIF, AMID, and EndoG in NCI-H28 cells (Fig. S2DeF). This indicates
that AIF, AMID, and EndoG are not implicated in DAPE-induced
caspase-independent apoptosis of NCI-H28 cells.
X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3,
-7, and -9. In response to apoptotic stimuli Smac/DIABLO is released
from the mitochondria and neutralizes inhibition of caspase-3, -7,
and -9 due to XIAP. Expression of XIAP and Smac/DIABLO in NCI-
H28 cells was not affected by DAPE (Fig. S3), indicating no impli-
cation of XIAP and Smac/DIABLO in DAPE-induced caspase-inde-
pendent apoptosis of NCI-H28 cells.
We next examined whether oxidative stress is implicated in
DAPE-induced apoptosis of NCI-H28 cells. DAPE-induced NCI-H28
cell death was signiﬁcantly inhibited by glutathione (GSH), an
antioxidant (Fig. 2A). In addition, the effect of DAPE was clearly
prevented by N-acetyl-L-cysteine (NAC), an antioxidant that is a
precursor of reduced GSH (Fig. 2B). These results suggest that DAPE
induces apoptosis of NCI-H28 cells by producing oxidants. DAPE-
induced NCI-H28 cell death was also attenuated by VAS-2870
(VAS), an inhibitor of NOX, or NSC23766 (NSC), an inhibitor of
Rac (Fig. 2C,D). Collectively, DAPE appears to stimulate NOX-
mediated ROS generation, responsible for apoptosis of NCI-H28
cells.
To obtain further evidence for this, we monitored ROS produc-
tion using carboxy-H2DCFDA. DAPE produced ROS in NCI-H28 cells
in a treatment time (1e20 min)-dependent manner, and the effect
was inhibited by GSH (Fig. 3A). DAPE-induced ROS production,
alternatively, was abrogated by VAS (Fig. 3B). Taken together, these
results imply that DAPE stimulates NOX-mediated ROS production
in NCI-H28 cells and that produced ROS is reduced by GSH.
ROS, produced by DAPE, might inhibit TrxR followed by Trx
reduction. To obtain evidence for this, we assayed TrxR activity in
NCI-H28 cells. Expectedly, DAPE suppressed TrxR activity in NCI-
H28 cells in a treatment time (10e120 min)-dependent manner,
reaching approximately 60% of basal levels at 120 min (Fig. 4).
Trx-SH2, which is reduced by TrxR, associates with ASK1, but
otherwise Trx-S2, a non-reduced from of Trx, dissociates andactivates ASK1. To address this issue, we examined an association of
Trx with ASK1 in immunoprecipitants using an anti-ASK1 antibody
from NCI-H28 cells. DAPE signiﬁcantly decreased immunoreactive
signals for Trx in a treatment time (10e120 min)-dependent
manner, reaching almost half of basal levels at 120 min (Fig. 5). This
indicates that DAPE decreases an association of ASK1 with Trx, i.e.,
DAPE increases free ASK1. Overall, these results show that DAPE
promotes NOX-mediated ROS production, causing a decrease in the
reductive form of Trx due to TrxR inhibition, allowing dissociation
of ASK1 from a complex with Trx.
Our next attempt was to see whether ASK1, dissociated from a
complex with Trx, is activated. ASK1 is activated by being phos-
phorylated at Thr845. DAPE apparently increased phosphorylation of
Fig. 3. DAPE promotes NOX-mediated ROS production in NCI-H28 cells. After 30-min loading of carboxy-H2DCFDA (10 mM), cells were treated DAPE (100 mM) in the presence and
absence of GSH (1 mM) (A) or VAS (1 mM) (B) for periods of time as indicated, and the ﬂuorescent signal intensities were measured. Typical ﬂuorescent images are shown in the
upper panel and time-course proﬁles of ROS production are shown in the lower panel. Scale bars, 50 mm. In the graphs, each point represents the mean (±SEM) ROS production
(n ¼ 4 independent experiments).
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(10e120 min)-dependent manner (Fig. 6A,B). This indicates that
DAPE activates ASK1 by dissociating ASK1 from a complex with Trx.
ASK1 phosphorylates and activates MKK3/6, which in turn, phos-
phorylates and activates p38 MAP kinase. ASK1, alternatively, phos-
phorylates and activates MKK4/7, which phosphorylates and
activates stress-activated protein kinases (SAPK)/c-Jun N-terminal
kinase (JNK). DAPE did not signiﬁcantly increase MKK3 phosphory-
lation at Ser189 (Fig. 6A,C), but a striking increase in p38 MAPK
phosphorylation at Thr180/Tyr182 was obtained (Fig. 6A, E). DAPE
signiﬁcantly increased JNKphosphorylation at Thr183/Tyr185onlyat
30-min treatment (Fig. 6A,F), while no remarkable increase in thephosphorylation of MKK4 at Ser257/Thr261 was found (Fig. 6A,D).
DAPE did not enhance phosphorylation of the other MAPK extra-
cellular signal-regulated kinase 1/2 (ERK1/2) at Thr202/Tyr204
(Fig. 6A,G). 1,2-Dilinoleoyl-sn-glycero-3-phosphoethanolamine
(DLPE) as well as DAPE increased ASK1 phosphorylation in NCI-
H28 cells, while DPPE and 1,2-dioleoyl-sn-glycero-3-phospho
ethanolamine (DOPE) had no effect (Fig. S4A,B). DLPE also
increased p38 MAPK phosphorylation, with much lesser potential
than that for DAPE, but otherwise no increase was obtained with
DOPE and DPPE (Fig. S4A,C). These results indicate that the effect of
DAPE on phosphorylation of ASK1 and p38 MAPK is not due to non-
speciﬁc action of phosphatidylethanolamine.
Fig. 4. DAPE attenuates TrxR activity in NCI-H28 cells. TrxR activity was monitored in
cells before and after treatment with DAPE (100 mM) for periods of time as indicated. In
the graph, each point represents the mean (±SEM) percentage of basal TrxR activities
(0 min) (n ¼ 4 independent experiments). P values, ANOVA followed by a Bonferroni
correction.
Fig. 5. DAPE dissociates ASK1 from a complex with Trx1 in NCI-H28 cells. Immuno-
precipitation using an anti-ASK1 antibody was carried out in cells before and after
treatment with DAPE (100 mM) for periods of time as indicated, followed by Western
blotting. In the graph, each column represents the mean (±SEM) signal intensity for
Trx1 relative to that for ASK1 (n ¼ 4 independent experiments). P values, ANOVA
followed by a Bonferroni correction. NS, not signiﬁcant.
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NCI-H28 cells (Fig. 7A,D). GSH also decreased DAPE-induced
phosphorylation of ASK1, ERK, and JNK, but not signiﬁcantly
(Fig. 7B,C,E). These results suggest that DAPE activates p38MAPK in
a ROS-dependent manner, possibly as mediated via ASK1.
To obtain further evidence for ASK1-dependent p38 MAPK
activation, we knocked-down ASK1 using the siRNA. Expression of
ASK1 was clearly suppressed in NCI-H28 cells transfected with the
siRNA silencing the ASK1-targeted gene, but the expression levels
were not affected by DAPE (Fig. 8A,B). DAPE-induced increase in
p38 MAPK phosphorylation was clearly inhibited by knocking-
down ASK1 (Fig. 8A,C), although DAPE-induced JNK phosphoryla-
tion was not affected (Fig. 8A,D). DAPE-induced NCI-H28 cell death
was signiﬁcantly prevented by knocking-down ASK1 (Fig. 8E).
Overall, these results indicate that DAPE activates p38 MAPK and
induces NCI-H28 cell death in an ASK1-dependent manner.
4. Discussion
In the present study, DAPE induced caspase-independent
apoptosis of NCI-H28 MPM cells. DAPE-induced NCI-H28 cell
death was inhibited by the antioxidants GSH and NAC or the NOX
inhibitor VAS. This suggests that DAPE stimulates NOX-mediated
ROS production, which triggers to induce apoptosis of NCI-H28
cells. In the NOX assay, DAPE actually increased ROS production
in NCI-H28 cells and the effect was canceled by VAS. This provides
evidence that DAPE stimulates NOX activity followed by ROS pro-
duction. ROS, alternatively, is recognized to be produced through
damaged mitochondria. DAPE perturbed mitochondrial membrane
potentials in NCI-H28 cells, but ROS production preceded mito-
chondrial damage (28). This implies that DAPE generates ROS by
activating NOX, but not due to mitochondrial damage. The NOX
family includes NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, and
DUOX2, which are composed of several subunits (30). Of them
NOX1 and NOX2 contain the small G-protein Rac1 in the subunits,
to regulate NOX activation (30). DAPE-induced NCI-H28 cell death
was signiﬁcantly attenuated by the Rac1 inhibitor NSC, suggesting
that DAPE may activate NOX by targeting Rac1.
Trx and TrxR are recognized to play a crucial role in the regu-
lation of cancer cell proliferation and invasion (20). TrxR reduces
Trx-S2 to Trx-SH2, which associates and inhibits ASK1; conversely,
Trx-S2, a non-reduced fromof Trx, dissociates and activates ASK1, to
induce apoptosis (31e33). We postulated that ROS produced by
DAPE might suppress TrxR activity. Indeed, DAPE attenuated TrxR
activity in NCI-H28 cells and signiﬁcantly decreased association of
ASK1 with Trx1. Moreover, DAPE enhanced phosphorylation of
ASK1 at Thr845 in NCI-H28. Taken together, these results indicate
that DAPE activates NOX to generate ROS, which inhibits TrxR,
allowing decrease in reduced Trx and dissociation of ASKI from a
complex with Trx, and then leading to activation of ASK1.
ASK1 activates MKK3/6 followed by p38 MAPK or MKK4/7 fol-
lowed by SAPK/JNK through sequential phosphorylation, and both
of p38 MAPK and SAPK/JNK are implicated in apoptosis (34,35).
DAPE markedly enhanced phosphorylation of p38 MAPK at Thr180/
Tyr182 in NCI-H28 cells, although no signiﬁcant increase in the
phosphorylation of MKK3 at Ser189 was not obtained. DAPE, on the
other hand, enhanced phosphorylation of JNK at Thr183/Tyr185
only at 30-min treatment, but phosphorylation of MKK4 at Ser257/
Thr261 was not affected. DAPE-induced increase in the phosphor-
ylation of p38MAPK, but not JNK, was abolished by GSH and clearly
prevented by knocking-down ASK1. In addition, DAPE-induced
NCI-H28 cell death was signiﬁcantly inhibited by knocking-down
ASK1. Overall, these results suggest that DAPE induces apoptosis
of NCI-H28 cells dominantly through an ASK1/MKK(3/6)/p38MAPK
pathway. The questions raised are as to: why in spite of signiﬁcant
Fig. 6. DAPE enhances phosphorylation of ASK1 and p38 MAPK in NCI-H28 cells. Cells were treated with DAPE (100 mM) for periods of time as indicated, followed by Western
blotting. Typical blotting images are shown in (A). In the graphs, each column represents the mean (±SEM) signal intensity for p-ASK1 (B), p-MKK3 (C), p-MKK4 (D), p-p38 (E), p-
JNK (F), or p-ERK (G) relative to that for each protein (n ¼ 4 independent experiments). P value, ANOVA followed by a Bonferroni correction. NS, not signiﬁcant.
A. Tsuchiya et al. / Journal of Pharmacological Sciences 129 (2015) 160e168 165
Fig. 7. DAPE-induced phosphorylation of p38 MAPK is abrogated by GSH in NCI-H28 cells. Cells were treated with DAPE (100 mM) for 30 min in the presence and absence of GSH
(1 mM), which was applied 1 h prior to DAPE treatment, and then, Western blotting was carried out. Typical blotting images are shown in (A). In the graphs, each column represents
the mean (±SEM) signal intensity for p-ASK1 (B), p-ERK (C), p-p38 (D), or p-JNK (E) relative to that for each protein (n ¼ 4 independent experiments). P value, unpaired t-test. NS,
not signiﬁcant.
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and why in spite of signiﬁcant inhibition of DAPE-induced p38
MAPK activation GSH did not inhibit DAPE-induced ASK1 activa-
tion. This may represent an additional DAPE-induced direct p38
MAPK activation pathway, regardless of MKK3/6.In summary, the results of the present study show that DAPE
stimulates NOX-mediated ROS production, which suppresses TrxR
activity and decreases reduced Trx, allowing ASK1 release from an
association with Trx, resulting in the sequential activation of ASK1/
MKK(3/6)/p38 MAPK, to induce caspase-independent apoptosis of
Fig. 8. DAPE-induced phosphorylation of p38 MAPK and cell death are dependent upon ASK1 in NCI-H28 cells. Cells, transfected with the NC siRNA or the ASK1 siRNA, were
untreated and treated with DAPE (100 mM) for 30 min, followed by Western blotting. (A) Typical blotting images. (B) In the graphs, each column represents the mean (±SEM) signal
intensity for ASK1 normalized by that for b-actin (n ¼ 4 independent experiments). (C) (D) The signal intensities for p-p38 (C) and p-JNK (D) were normalized by those for each
unphosphorylated protein. In the graphs, each column represents the mean (±SEM) signal intensity for p-p38 (C) and p-JNK (D) relative to that for each (n ¼ 4 independent
experiments). (E) Cells, transfected with the NC siRNA and the ASK1 siRNA, were treated with DAPE (100 mM) for 48 h, followed by MTT assay. In the graph, each column represents
the mean (±SEM) percentage of basal levels (MTT intensities for cells before treatment with DAPE) (n ¼ 4 independent experiments). P values, unpaired t-test. NS, not signiﬁcant.
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A. Tsuchiya et al. / Journal of Pharmacological Sciences 129 (2015) 160e168168NCI-H28 MPM cells. This may establish a new apoptotic pathway
relevant to DAPE signaling.
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